Clearmind Medicine CMND
NASDAQ CMND
$5.99 -0.13 (-2.04%)
As of: Oct 21, 2026 · 3:52 PM EDT

Clearmind Medicine (CMND) Net Margin (2023 - 2025)

Updated

Clearmind Medicine's Net Margin came in at -4610.81% for FY2022 (year ended Oct 31, 2022), down 1967.37 percentage points from -2643.44% in FY2021.

Analysis

Clearmind Medicine (CMND) Net Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Net Margin at -2643.44% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 Clearmind Medicine 9,526.05 -39.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2025 -89.26%
Jul 31, 2025 -1,282.43%
Jan 31, 2025 -231.01%
Oct 31, 2024 -110.79%
Apr 30, 2024 -210.21%
Jul 31, 2023 -110.39%
Apr 30, 2023 -34,803.59%
Jan 31, 2023 -6,590.18%
API Access

Clearmind Medicine Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=CMND&period=max&api_key=YOUR_API_KEY